Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
WCAS XIV has agreed to acquire Select Medical Holdings, a healthcare services other business in Delaware, for $16.50 per share. Select Medical Holdings operates healthcare services focused on post-acute care delivery, supporting patient rehabilitation and related clinical programs across its network. WCAS XIV acquisitions in healthcare M&A target scalable care delivery platforms in DE acquisitions to expand private equity acquisition exposure in healthcare deals DE. The going private acquisition is structured as a merger with a wholly owned subsidiary of WCAS XIV, with stockholder approval sought at a June 26, 2026 special meeting.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026